GOLM1 and hepatocellular carcinoma: Our study found that PKM2 or GP73 attenuates the anti-tumor effect of sorafenib, suggesting that searching for specific PKM2 or GP73 inhibitors and combining them with sorafenib may be an effective treatment for HCC.